前列腺癌的免疫疗法。 - Suppr

Suppr

超能文献

Immunotherapy of prostate cancer.

作者信息

Doehn Christian

出版信息

Eur Urol. 2008 Apr;53(4):681-3; discussion 684-5. doi: 10.1016/j.eururo.2007.12.038. Epub 2008 Jan 3.

DOI:10.1016/j.eururo.2007.12.038

PMID:18248878

Abstract

摘要

相似文献

Immunotherapy of prostate cancer.

Eur Urol. 2008 Apr;53(4):681-3; discussion 684-5. doi: 10.1016/j.eururo.2007.12.038. Epub 2008 Jan 3.

Advances in specific immunotherapy for prostate cancer.

Eur Urol. 2008 Apr;53(4):694-708. doi: 10.1016/j.eururo.2007.11.043. Epub 2007 Nov 26.

The immunotherapy of prostate and bladder cancer.

BJU Int. 2005 Oct;96(5):728-35. doi: 10.1111/j.1464-410X.2005.05772.x.

Immunotherapeutics in development for prostate cancer.

Oncologist. 2009 Apr;14(4):391-8. doi: 10.1634/theoncologist.2008-0240. Epub 2009 Apr 2.

Target molecules in specific immunotherapy against prostate cancer.

Int J Clin Oncol. 2003 Aug;8(4):193-9. doi: 10.1007/s10147-003-0332-x.

Harnessing immunity for cancer marker discovery.

Nat Biotechnol. 2003 Jan;21(1):37-8. doi: 10.1038/nbt0103-37.

Prostate cancer vaccines: maximizing a suboptimal immune response for improved outcome.

Clin Adv Hematol Oncol. 2007 Dec;5(12):972-80.

Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.

Acta Oncol. 2005;44(6):610-27. doi: 10.1080/02841860510007477.

Current approaches in ovarian cancer vaccines.

Minerva Ginecol. 2004 Dec;56(6):515-27.

Current immunotherapeutic strategies in prostate cancer.

Surg Oncol Clin N Am. 2007 Oct;16(4):861-71, x. doi: 10.1016/j.soc.2007.07.009.

引用本文的文献

Human prostatic acid phosphatase: structure, function and regulation.

Int J Mol Sci. 2013 May 21;14(5):10438-64. doi: 10.3390/ijms140510438.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Immunotherapy of prostate cancer.

Eur Urol. 2008 Apr;53(4):681-3; discussion 684-5. doi: 10.1016/j.eururo.2007.12.038. Epub 2008 Jan 3.

Advances in specific immunotherapy for prostate cancer.

Eur Urol. 2008 Apr;53(4):694-708. doi: 10.1016/j.eururo.2007.11.043. Epub 2007 Nov 26.

The immunotherapy of prostate and bladder cancer.

BJU Int. 2005 Oct;96(5):728-35. doi: 10.1111/j.1464-410X.2005.05772.x.

Immunotherapeutics in development for prostate cancer.

Oncologist. 2009 Apr;14(4):391-8. doi: 10.1634/theoncologist.2008-0240. Epub 2009 Apr 2.

Target molecules in specific immunotherapy against prostate cancer.

Int J Clin Oncol. 2003 Aug;8(4):193-9. doi: 10.1007/s10147-003-0332-x.

Harnessing immunity for cancer marker discovery.

Nat Biotechnol. 2003 Jan;21(1):37-8. doi: 10.1038/nbt0103-37.

Prostate cancer vaccines: maximizing a suboptimal immune response for improved outcome.

Clin Adv Hematol Oncol. 2007 Dec;5(12):972-80.

Gene therapy and immunotherapy of prostate cancer: adenoviral-based strategies.

Acta Oncol. 2005;44(6):610-27. doi: 10.1080/02841860510007477.

Current approaches in ovarian cancer vaccines.

Minerva Ginecol. 2004 Dec;56(6):515-27.

Current immunotherapeutic strategies in prostate cancer.

Surg Oncol Clin N Am. 2007 Oct;16(4):861-71, x. doi: 10.1016/j.soc.2007.07.009.

引用本文的文献

Human prostatic acid phosphatase: structure, function and regulation.

Int J Mol Sci. 2013 May 21;14(5):10438-64. doi: 10.3390/ijms140510438.